Skip to main content

Day: March 11, 2026

Sogeclair: annual results for 2025

ANNUAL RESULTS FOR 2025Consolidated turnover: €160.3M, +2.1% (at constant exchange rate: +3.0%)EBITDA (1) = €18.7M, +13.0%Net Result = €6.8M, +11.8%Dividend = €1.0 per share, +4.2% Blagnac, France, March 11th, 2026, after closing of the Stock Market. SOGECLAIR, supplier of innovative solutions with high added value for a safer and less-consuming mobility publishes its financial results for the year ended December 31, 2025. SOGECLAIR is listed on Euronext Growth in Paris. The Board of Directors, which met on March 10th, 2026, has approved the financial statements for the year ended December 31, 2025. The audit procedures on the annual accounts have been carried out.All interim management figures improved, with EBITDA at 11.7% of turnover, increasing to €18.7 million, operating income at 6.4% of turnover, up significantly to €10.2 million,...

Continue reading

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 11 March 2026

Sanoma Corporation, Stock exchange release, 11 March 2026 at 18:30 EET SANOMA CORPORATION: ACQUISITION OF OWN SHARES 11 March 2026 Nasdaq Helsinki Ltd:Date 11 March 2026  Exchange transaction Buy  Share class SANOMA  Amount 26,439  Average price/share, EUR 8.9517  Highest price/share, EUR 9.0400  Lowest price/share, EUR 8.8600  Total cost, EUR 236,674.00       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052. The company holds a total of 795,537 of its own shares (SANOMA) including the shares acquired on 11 March 2026. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Sanoma Corporation Skandinaviska Enskilda Banken AB...

Continue reading

Lassila & Tikanoja Plc: Share Repurchase 11.3.2026

Lassila & Tikanoja Plc, STOCK EXCHANGE RELEASE, 11 March 2026 at 6.30 PM (EET)                        Lassila & Tikanoja Plc: Share Repurchase 11.3.2026                 In the Helsinki Stock Exchange                     Trade date           11.3.2026        Bourse trade         Buy        Share                  LASTIK        Amount             12 000 Shares      Average price/ share    7,6953 EUR      Total cost            92 343,60 EUR                            Lassila & Tikanoja Plc now holds a total of 65 712 shares      including the shares repurchased on 11.3.2026                   The share buybacks are executed in compliance with Regulation       No. 596/2014 of the European Parliament and Council (MAR) Article 5    and the Commission Delegated Regulation...

Continue reading

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) — PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms. The collaboration focused on evaluating and strengthening Porosome Therapeutics’ intellectual property portfolio to support future partnerships, commercialization efforts, and capital strategy initiatives. PatentVest conducted a comprehensive IP portfolio audit, global patent landscape analyses, competitive benchmarking, and strategic partner assessment. Porosome Therapeutics is advancing Porosome Reconstitution Platforms (PRPs), a novel approach to restore cells’ native secretory machinery. Unlike traditional therapies that suppress or modulate...

Continue reading

Initiation of share buyback programme in Gabriel Holding A/S

The Board of Directors of Gabriel Holding A/S has today resolved to repurchase the company’s own shares based on the authorization granted at the Annual General Meeting on 11 December 2025. The authorization is valid for 5 years and up to 20% of the share capital. At the initiation of the share buyback programme, Gabriel Holding A/S holds no treasury shares. The purpose of the share buyback programme is to ensure an appropriate holding of treasury shares, which may be used in connection with acquisitions and/or as the basis for share-based remuneration programmes for key employees of the company. Shares not used for these purposes are expected to be cancelled, resulting in a reduction of the company’s share capital in accordance with the provisions of the Danish Companies Act. The share buyback programme will run from 16 March 2026 through...

Continue reading

Toll Brothers Announces New Luxury Home Community Coming Soon to Mapleton, Utah

Toll Brothers at Mapleton – Heights Collection offers breathtaking views and elegant home designs MAPLETON, Utah, March 11, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Utah community, Toll Brothers at Mapleton – Heights Collection, is coming soon to Mapleton, Utah. This highly anticipated community will feature beautiful new construction homes with mountain views in a charming small-town setting. The community is scheduled to open for sale in spring 2026, and the model home will be featured in the 2026 Utah Valley Parade of Homes. A second collection, Toll Brothers at Mapleton – Crest Collection, will open in late summer 2026.Toll Brothers at Mapleton – Heights Collection will feature elegant single- and two-story home...

Continue reading

Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite

Clinician reviewing digital pathology slideClinician reviewing digital pathology slideMarch 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows. Philips IntelliSite Pathology Solution on HealthSuite¹, powered by Amazon Web Services (AWS) is a fully cloud-enabled digital pathology solution that helps pathology laboratories adopt and scale digital workflows without the complexity of on-premise infrastructure....

Continue reading

Scripps Sports announces 2026 NWSL on ION coverage plans

New season to feature eight tripleheaders and new studio analyst team; Coverage kicks off March 14NWSL on ION 2026NWSL on ION 2026ATLANTA, March 11, 2026 (GLOBE NEWSWIRE) — Following a record-setting 2025 season, Scripps Sports today unveiled its broadcast plans for the third season of the National Women’s Soccer League (NWSL) on ION, kicking off Saturday, March 14, with a primetime tripleheader – the first of eight tripleheader Saturdays this year. NWSL on ION will again showcase top matches from across the league every Saturday night of the regular season. ION is one of the most-watched networks on television and is available on pay TV, connected TV and free, ad-supported streaming platforms and over-the-air in 126 million homes. The March 14 tripleheader kicks off the 2026 season for the NWSL on ION and begins at 4...

Continue reading

Belize Advances National Eye Health with Launch of WHO SPECS 2030 Initiative

BELIZE CITY, Belize, March 11, 2026 (GLOBE NEWSWIRE) — Belize has taken a significant step toward ensuring that every person in the country has access to quality, affordable eye care, with the official launch of the World Health Organization (WHO) SPECS 2030 initiative. The national launch and planning workshop brought together representatives from the Ministry of Health and Wellness (MOHW), the Ministry of Foreign Affairs, Foreign Trade, Education, Culture, Science and Technology, the Belize Council for the Visually Impaired (BCVI), the OneSight EssilorLuxottica Foundation, the World Health Organization and the Pan American Health Organization (PAHO). Participants convened to assess the current state of eye health services in Belize, identify gaps, and chart a clear path forward. “With the launch of the WHO SPECS 2030 initiative,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.